Kelly Johnson | Authors


Advanced Prostate Cancer Clinics Begin to Mesh With Practices

December 18, 2015

Urologists face a challenge in delineating the optimal sequence of treatment more and more as the goal for treating prostate cancer moves toward greater use of targeted therapies. While these treatment eradicate disease, urologists must minimize the risk of adverse events.

Uridine Triacetate Approved by FDA to Deter Chemo Overdose and Toxicities

December 12, 2015

Uridine triacetate (Vistogard) has been given a green light by the FDA to treat adult and pediatric patients who have severe or life-threatening toxicities within 4 days of treatment following an overdose of 5-fluorouracil (5-FU) or capecitabine.